NeoDynamics receives new order from large hospital in Germany
NeoDynamics receives new order from large hospital in Germany.
Order momentum starts to build-up in Europe and NeoDynamics clearly shows the Pro's with the NeoNavia system in breast biopsies and especially the Flexipulse needle.
CEO Anna Eriksrud commented on the order “We are very pleased to announce yet another order for FlexiPulse needles from Germany. Western Rhineland-Palatinate Hospital is among the top 100 rated and distinguished hospitals in Germany and it serves as academic training hospital for the University of Mains. It has a large interdisciplinary sonography department performing all kinds of biopsies. This order clearly demonstrates the commercial viability of our innovative pulse technology and its increasing acceptance by leading practitioners” says Anna Eriksrud, CEO."
Read more: https://www.neodynamics.com/en-gb/press-releases/article/868e3c84-b292-4707-a5f1-6225cd23aee0/neodynamics-receives-new-order-from-large-hospital-in-germany
Disclaimer: HC Andersen Capital receives payment from NeoDynamics for a Digital IR/Corporate Visibility subscription agreement. Claus Thestrup 8:20 AM 19-10-2023.
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Read more on company page